trending Market Intelligence /marketintelligence/en/news-insights/trending/fu0uaxjgdtd2vijgmuoncq2 content esgSubNav
In This List

AmpliPhi Biosciences plans $3M common stock offering

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection

Video

S&P Capital IQ Pro | Powered by Advanced Visualization

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge


AmpliPhi Biosciences plans $3M common stock offering

San Diego-based AmpliPhi Biosciences Corp. agreed to sell 2,743,640 common shares at $1.10 per share in an offering to certain institutional investors.

The company, which develops therapies for infections, expects gross proceeds of about $3 million. AmpliPhi plans to use the net proceeds for general corporate purposes.

H.C. Wainwright & Co. is the exclusive placement agent for the offering, which is expected to close by March 22.